Why the study?
Many women with angina have no obstructive CAD yet face impaired prognosis, and whether routine assessment of coronary microvascular dysfunction is feasible and predictive of adverse outcomes was unknown.
Does coronary flow velocity reserve (CFVR) assessed by echocardiography predict adverse outcomes in women with angina and no obstructive coronary artery disease?
Population
1853 women with angina and no obstructive CAD on angiogram
Comparison
Coronary flow velocity reserve assessment by Doppler echocardiography
Design
Prospective cohort study
Follow-up
Median 4.5 years
Key result
A 0.1 unit decrease in coronary flow velocity reserve was associated with increased risk of cardiovascular death, MI, heart failure, stroke, or revascularization (HR 1.05; 95% CI 1.01-1.09; P=0.01).
Authors
Loading...
CMD assessment by echocardiography may identify higher-risk women; leaves open whether targeting CMD improves outcomes.
Cohort (n=1,853)
Does coronary flow velocity reserve (CFVR) assessed by echocardiography predict adverse outcomes in women with angina and no obstructive coronary artery disease?
Hazard Ratio: 1.05 (95% CI 1.01–1.09)
p-value: p=0.01
Non-invasive assessment of coronary flow velocity reserve by echocardiography is feasible and independently predicts adverse cardiovascular outcomes in women with angina and no obstructive CAD.
Schrøder et al. (2020) conducted a cohort in Angina and no obstructive coronary artery disease (n=1,853). Coronary flow velocity reserve (CFVR) was evaluated on Composite outcome of cardiovascular death, myocardial infarction (MI), heart failure, stroke, and coronary revascularization (HR 1.05, 95% CI 1.01-1.09, p=0.01). A 0.1 unit decrease in coronary flow velocity reserve was associated with increased risk of cardiovascular death, MI, heart failure, stroke, or revascularization (HR 1.05; 95% CI 1.01-1.09; P=0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: